The efficacy and safety of a new fixed-dose combination of amodiaquine and artesunate in young African children with acute uncomplicated Plasmodium falciparum
Open accessThe DOI matches its Crossref record.
Abstract
BACKGROUND: Artesunate (AS) plus amodiaquine (AQ) is one artemisinin-based combination (ACT) recommended by the WHO for treating Plasmodium falciparum malaria. Fixed-dose AS/AQ is new, but its safety and efficacy are hitherto untested. METHODS: A randomized, open-label trial was conducted comparing the efficacy (non-inferiority design) and safety of fixed (F) dose AS (25 mg)/AQ (67.5 mg) to loose (L) AS (50 mg) + AQ (153 mg) in 750, P. falciparum-infected children from Burkina Faso aged 6 months to 5 years. Dosing was by age. Primary efficacy endpoint was Day (D) 28, PCR-corrected, parasitological cure rate. Recipients of rescue treatment were counted as failures and new infections as cured. Documented, common toxicity criteria (CTC) graded adverse events (AEs) defined safety. RESULTS: Recruited and evaluable children numbered 750 (375/arm) and 682 (90.9%), respectively. There were 8 (AS/AQ) and 6 (AS+AQ) early treatment failures and one D7 failure (AS+AQ). Sixteen (AS/AQ) and 12 (AS+AQ) patients had recurrent parasitaemia (PCR new infections 10 and 6, respectively). Fourteen patients per arm required rescue treatment for vomiting/spitting out study drugs. Efficacy rates were 92.1% in both arms: AS/AQ = 315/342 (95% CI: 88.7-94.7) vs. AS+AQ = 313/340 (95% CI: 88.6-94.7). Non-inferiority was demonstrated at two-sided alpha = 0.05: Delta (AS+AQ - AS/AQ) = 0.0% (95% CI: -4.1% to 4.0%). D28, Kaplan Meier PCR-corrected cure rates (all randomized children) were similar: 93.7% (AS/AQ) vs. 93.2% (AS+AQ) Delta = -0.5 (95% CI -4.2 to 3.0%). By D2, both arms had rapid parasite (F & L, 97.8% aparasitaemic) and fever (97.2% [F], 96.0% [L] afebrile) clearances.Both treatments were well tolerated. Drug-induced vomiting numbered 8/375 (2.1%) and 6/375 (1.6%) in the fixed and loose arms, respectively (p = 0.59). One patient developed asymptomatic, CTC grade 4 hepatitis (AST 1052, ALT 936). Technical difficulties precluded the assessment and risk of neutropaenia for all patients. CONCLUSION: Fixed dose AS/AQ was efficacious and well tolerated. These data support the use of this new fixed dose combination for treating P. falciparum malaria with continued safety monitoring. TRIAL REGISTRATION: Current Controlled Trials ISRCTN07576538.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Bompart, F., Kiechel, J.-R., Sebbag, R., & Pecoul, B. (2011) · Malaria Journal · doi:10.1186/1475-2875-10-143 · Cited by 58
Self-citationCairns, M., Cisse, B., Sokhna, C., Cames, C., Simondon, K., Ba, E. H., Trape, J.-F., Gaye, O., Greenwood, B. M., & Milligan, P. J. M. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01161-09 · Cited by 26
“cases (13, 16), but the priorities may be different for IPT”
BackgroundLacaze, C., Kauss, T., Kiechel, J.-R., Caminiti, A., Fawaz, F., Terrassin, L., Cuart, S., Grislain, L., Navaratnam, V., Ghezzoul, B., et al. (2011) · Malaria Journal · doi:10.1186/1475-2875-10-142 · Cited by 24
“This paper recounts the development process that led to the formulation of ASAQ in bilayer tablets up to the clinical batches used for initial clinical studies performed in Burkina Faso [8], and subsequently transferred to commercial partners identified by DNDi (Sanofi-Aventis in 2005, Bompart F, Kiechel JR, Sebbag R,…”
Self-citationFixed artesunate–amodiaquine combined pre-formulation study for the treatment of malaria
Kauss, T., Fawaz, F., Guyot, M., Lagueny, A.-M., Dos Santos, I., Bonini, F., Olliaro, P., Caminiti, A., & Millet, P. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.05.038 · Cited by 20
Self-citationGerstl, S., Namagana, A., Palacios, L., Mweshi, F., Aprile, S., & Lima, A. (2015) · Malaria Journal · doi:10.1186/s12936-015-0933-7 · Cited by 11
Metadata
- Authors
- Sirima, S. B., Tiono, A. B., Gansané, A., Diarra, A., Ouédraogo, A., Konaté, A. T., Kiechel, J. R., Morgan, C. C., Olliaro, P. L., & Taylor, W. R.
- Venue
- Malaria Journal
- Published
- 2009-03-16
- Volume
- 8
- Issue
- 1
- Pages
- 48-48
- ISSN
- 1475-2875 (ISSN-L)
- OpenAlex
- W1976470115
- Cited by
- 63
- References
- 0
- FWCI
- 10.50
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The efficacy and safety of a new fixed-dose combination of amodiaquine and artesunate in young African children with acute uncomplicated Plasmodium falciparum. https://app.cochat.ai/papers/10.1186/1475-2875-8-48
- The paper
- Sirima, S. B., Tiono, A. B., Gansané, A., Diarra, A., Ouédraogo, A., Konaté, A. T., Kiechel, J. R., Morgan, C. C., Olliaro, P. L., & Taylor, W. R. (2009). The efficacy and safety of a new fixed-dose combination of amodiaquine and artesunate in young African children with acute uncomplicated Plasmodium falciparum. Malaria Journal. https://doi.org/10.1186/1475-2875-8-48
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.